-- Basel, Switzerland - In an extraordinary leap forward for microbiome-based therapeutics, Swiss Biome has revealed the world’s first metabolite complex designed to harness the power of the skin to support brain health. This ground breaking discovery promises to redefine wellness as we know it, offering a thrilling new frontier where science and nature converge in ways never before imagined.
Based at Switzerland Innovation Park Basel, Dr. Bejit Ideas and his team of researchers unearthed a game-changing bacterial strain from the glaciers of the Alps. These ancient, ice-covered soils, a true testament to nature’s resilience, are home to microbial life that thrives in extreme conditions of freezing temperatures and limited resources. It is this incredible resilience that has inspired Swiss Biome’s revolutionary approach to human health.
“The glaciers of the Alps, where only the toughest microbes survive, have given us an unexpected gift: a powerful, naturally occurring solution to support brain health,” said Dr. Celine Klotz, a leading researcher at Swiss Biome. “The adaptability of these microbes is astonishing, and now, we’re unlocking their full potential for human well-being.”
Harnessing this discovery, Swiss Biome applied its state-of-the-art co-culture fermentation technology to combine multiple bacterial strains, leading to the creation of a cutting-edge metabolite complex. Early laboratory studies are nothing short of astonishing, showing that this complex can modulate mitochondrial activity in skin cells and stimulate brain stem cell function, two critical components of brain health. As we age, maintaining cognitive function becomes increasingly vital, and this breakthrough could offer a powerful solution for preserving and even enhancing brain health.
“We’re on the edge of something truly revolutionary. Our next step? Transitioning from ex-vivo studies to human trials, where we’ll see first hand how these findings can transform cognitive function,” said Dr. Yuki Ikeda, a leading clinical researcher from Tokyo Innovation Labs, where clinical trials are already set to begin.
Swiss Biome’s ultimate mission is to develop microbiome-based therapies that can prevent or even reverse neurological conditions such as memory loss, dementia, and Alzheimer’s disease. With cognitive diseases rapidly becoming the leading cause of mortality in developed countries, this discovery could not come at a more critical time.
This breakthrough doesn’t just put Swiss Biome at the forefront of a new era in therapeutic innovation, it creates an entirely new category of treatment. By bridging the gap between dermatology and neurology, Swiss Biome offers a unique approach to wellness that taps into the resilience of nature itself. And with the skin and brain sharing similar stem cells, this path of research could lead to the development of a whole new generation of life-changing therapeutics.
The future of cognitive health is here and it starts with the power of the skin.
Contact Info:
Name: Dr. Yuki Ikeda
Email: Send Email
Organization: Swiss Biome Institute
Website: https://www.swiss-biome.com/
Release ID: 89188394
If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release, or if there is a need for a press release takedown, we urge you to notify us without delay at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team will be available to promptly respond within 8 hours – ensuring swift resolution of identified issues or offering guidance on removal procedures. Delivering accurate and reliable information is fundamental to our mission.
